Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Profit warning: NoHo Partners lowers its guidance for 2021

NoHo Partners PlcINSIDE INFORMATION 21 December 2021 at 23:22Profit warning: NoHo Partners lowers its guidance for 2021NoHo Partners Plc lowers its profit guidance for 2021, published on 9 November 2021, as a result of strict restrictions on restaurant opening hours, local restrictions on gatherings and the Finnish government’s decision to abolish the use of COVID-19 passport. As a consequence, the company will have to close almost all of its restaurants in Finland and lay off nearly all of its personnel.According to the company’s new outlook, the operating cash flow in the fourth

Nordea Bank Abp: Repurchase of own shares on 21.12.2021

Nordea Bank AbpStock exchange release – Changes in company’s own shares21.12.2021 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 21.12.2021 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 444,027 10.29 4,569,384.39XHEL 282,778 10.30 2,911,651.95CEUX 365,514 10.29 3,762,091.83AQEU 42,235 10.29

Ortoma Signs Agreement for Exclusive Distribution Rights in Japan

Ortoma signs agreement with Johnson & Johnson K.K. for exclusive distribution rights in Japan of the Ortoma Treatment Solution for hip surgery. It is the first agreement that the company executes with a global strategic partner. The agreement allows for the possibility to expand the partnership to other global markets.Ortoma is the provider of the Ortoma Treatment Solution (OTS), which includes OTS Hip Plan and OTS Hip Guide for pre-operative planning, intra-operative navigation, and post-operative follow-up of hip implant surgical procedures. The OTS platform is a surgical system that is

Provident CRM launches new website

The website incorporates design enhancements, usability and site speed improvements, and many other features created to make the user experience more enjoyableDublin, 21 December 2021 – Provident CRM, an independent digital solutions consultancy dedicated to delivering bespoke technologies to drive customer success, is thrilled to announce the launch of its new website, www.providentcrm.com. The redesigned website offers a clean, modern look, with a better user-centric experience and improved navigation, functionality and responsiveness. Users can easily find educational information and

Five announced acquisitions are estimated to contribute SEK 246-316 million in operational EBIT during FY22/23 and SEK 519-689 million during FY23/24

Embracer Group AB (“Embracer”) and its subsidiaries have as previously communicated on 21 December 2021 entered into five acquisition agreements (the “Transactions”). The Transactions improve the group's capabilities within game publishing and development, work-for-hire, comics publishing, film & TV production. The acquired businesses are expected to contribute to operational EBIT in the range of SEK 246-316 million during FY 22/23 and SEK 519-689 during FY 23/24. These figures exclude any commercial synergies or planned M&A.The aggregated day one purchase price for the Transactions amounts

Eurocine Vaccines resolves on scientific advice with the Swedish Medical Products Agency ahead of clinical trial application

The Board of Directors of Eurocine Vaccines has resolved to request scientific advice from the Swedish Medical Products Agency ahead of submitting the clinical trial application with the company’s vaccine candidate against chlamydia. The scientific advice aims to strengthen Eurocine Vaccines´ documentation and maximize the probability of a swift approval of the application. As a consequence, Eurocine Vaccines plans to initiate the clinical study in the first half-year 2023. Prior to the clinical study with the vaccine candidate against chlamydia, a scientific advice will be

BEWI ASA announces publication of bond prospectus

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933), AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, UNITED KINGDOM OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. On 8 November 2021, BEWI ASA (“BEWI“) announced successful placement of subsequent bonds under existing

EU’s mass balance approach increases value of Enviro’s oil following ISCC EU certification

The ISCC certification obtained in September for Enviro’s recovered pyrolysis oil has made it significantly more attractive to various fuel producers as a raw material. The reason is that this certification, combined with the EU mass balance approach, which forms part of the EU Renewable Energy Directive, means that the oil can be commercialized by fuel producers as 100 percent renewable. “Our oil can thus strongly improve the producers’ ability to meet the reduction demands that are based on taxation in relation to the proportion of fossil raw material,” says Thomas Sörensson, CEO of

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 21.12.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 21.12.2021 at 18:30 EET ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 21.12.2021 Date 21.12.2021Exchange transaction BuyShare class ALEXAmount 78Average price/share 8.0400 EURHighest price/share 8.0400 EURLowest price/share 8.0400 EURTotal price 627.12 EUR The shares held by Alexandria Pankkiiriliike Oyj on 21.12.2021: ALEX 43,456 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

Terveystalo Plc: SHARE REPURCHASE 21.12.2021

Terveystalo Plc ANNOUNCEMENT  21.12.2021 Terveystalo Plc: SHARE REPURCHASE 21.12.2021 In the Helsinki Stock Exchange Trade date           21.12.2021Bourse trade         BuyShare                  TTALOAmount             24 000 SharesAverage price/ share    11,3312 EURTotal cost            271 948,80 EUR Terveystalo Plc now holds a total of 1 619 382 sharesincluding the shares repurchased on 21.12.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

Pandox acquires extended stay in Edinburgh for MGBP 40.5

Pandox AB (publ) has entered into an agreement to acquire Adagio Aparthotel Edinburgh with 146 rooms in central Edinburgh, Scotland. The total transaction value amounts to approximately MGBP 40.5 including transfer tax and will be financed by cash and existing credit facilities. The tenant is Adagio Aparthotels and Pandox expects the hotel to contribute approximately MGBP 2.2 in net operating income per year in a normalised market. The acquisition is closed and accessed per 21 December 2021. The hotel is reported under the business segment Property Management. “We are very pleased to

TOMRA Systems ASA announces new CFO

On March 1[st], 2022, Eva Sagemo will take over as CFO of Tomra Systems ASA. “I am pleased that we have found such a strong candidate internally and look forward to welcome Eva Sagemo into the Executive Leadership Team where her experience and financial insights will be highly valued,” said Tove Andersen, President and CEO of TOMRA. Having been in TOMRA since 2012, Eva brings extensive TOMRA business insight, broad expertise in finance, as well as compliance and audit. Over the course of her career, Eva has grown her breadth across the finance function and various transformation

Thomas Chalkidis appointed new Managing Director for Helbio S.A.

Thomas Chalkidis has been appointed new Managing Director for Metacon’s daughter company Helbio S.A. in Patras, Greece. At the same time, he assumes the role as Head of Reforming Technologies within Metacon Group.[En bild som visar person, vägg, inomhus, står Automatiskt genererad beskrivning]Thomas Chalkidis takes over the leadership of Helbio after Professor Xenophon Verykios who retires after a long, successful scientific and entrepreneurial career in the field of catalytic steam reforming and related process chemical fields. Prof. Verykios is the founder of Helbio and the inventor

#21-420 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

SBB receives competition clearance for the acquisition of Amasten

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law. On 20 December 2021, Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) announced a mandatory public offer to the

#21-421 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Presentation materials for today's conference call with Aker BP and Lundin Energy

Please find attached the presentation materials for today's conference call with Aker BP and Lundin, to be held at 16:00 CET.  The conference call will be available as a live webcast on www.akerbp.com/en.  To participate in the conference call, please use the dial-in numbers and passcode below. Phone number Norway:  +47 2350 0347   Phone number UK: +44 (0)33 033 69600  Participant Passcode:  959538 AKRBP_LUNE_TRANSACTION.pdf 

Aker ASA: Aker BP acquires Lundin Energy’s oil and gas business

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Reference is made to Aker BP ASA’s (“Aker BP”) merger announcement today regarding the agreement with Lundin Energy AB (“Lundin Energy”) to acquire Lundin Energy’s oil and gas related activities, through a statutory merger, to create the E&P company of

Aker BP: Key information related to 2022 cash dividends

The following sets out the planned cash dividends to be paid by Aker BP in 2022. The dates are indicative. First quarter 2022: · Dividend amount: USD 0.475 per share · Declared currency: USD · Last day of trading including right: 14 February 2022 · Ex-date: 15 February 2022 · Record date: 16 February 2022 · Payment date: 23 February 2022 · Date of approval: 21 December 2021 Second quarter 2022: · Dividend amount: USD 0.475 per share · Declared currency: USD · Last day of trading including right: 2 May 2022 · Ex-date: 3 May 2022 · Record date: 4

Aker BP acquires Lundin Energy’s oil and gas business

The E&P company of the future Reference is made to the merger announcement regarding the agreement with Lundin Energy AB (“Lundin Energy”) where Aker BP ASA (“Aker BP”) is to acquire Lundin Energy’s oil and gas related activities, through a statutory merger, to create the E&P company of the future. The company will be the largest listed E&P company focused purely on the Norwegian Continental Shelf (“NCS”). The transaction values the acquired assets to approximately NOK 125 billion. The merger of Aker BP and Lundin Energy unites two highly successful E&P companies which have both been

There are no items matching the current filter
There are no more items matching the current filter
Back to top